Gene Name: HHIPL1 (HHIP-like 1)
UniProt ID: Q96JK4 (Human)
Protein Function: Belongs to the glucose/sorbosone dehydrogenase family and contains a folate-binding domain, suggesting involvement in folate metabolism or transport .
Species Homology: High conservation across mammals (e.g., 92% homology in horses, 100% in humans, 92% in mice) .
HIPL1 antibodies are utilized in:
Expression Studies: Mapping HIPL1 protein distribution in tissues or cell lines.
Functional Assays: Investigating interactions with folate derivatives or other metabolic partners.
Disease Research: Preliminary studies suggest potential links to cancers, though specific mechanisms remain under investigation .
Structural Insights: HIPL1’s folate-binding domain implies a role in cellular metabolism, possibly influencing pathways disrupted in cancer or developmental disorders .
Cross-Species Utility: High homology in mammals supports translational research using animal models .
Commercial Availability: Multiple vendors offer HIPL1 antibodies (e.g., Thermo Fisher, Sigma-Aldrich), validated for consistency in WB and IHC .
| Antibody ID | Host | Clonality | Applications | Validation |
|---|---|---|---|---|
| PA5-70457 | Rabbit | Polyclonal | WB, IHC, ELISA | Species reactivity, peptide ELISA |
| HPA017964 | Rabbit | Polyclonal | WB, IHC | Enhanced validation (RNAseq) |
Functional Data Gaps: The exact physiological role of HIPL1 and its relevance to diseases like cancer remain poorly characterized.
Therapeutic Potential: No HIPL1-targeted therapies are in clinical trials as of 2025, unlike antibodies for targets such as HIV (e.g., VRC01LS) .
Research Needs: Further studies are required to elucidate HIPL1’s interaction networks and validate its biomarker potential.